دورية أكاديمية
أعرض في EDS

Association of Single Nucleotide Polymorphisms of Cytokine Genes with Depression, Schizophrenia and Bipolar Disorder.

التفاصيل البيبلوغرافية
العنوان: Association of Single Nucleotide Polymorphisms of Cytokine Genes with Depression, Schizophrenia and Bipolar Disorder.
المؤلفون: Mikhalitskaya EV; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia., Vyalova NM; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia., Ermakov EA; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia., Levchuk LA; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia., Simutkin GG; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia., Bokhan NA; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia., Ivanova SA; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia.
المصدر: Genes [Genes (Basel)] 2023 Jul 17; Vol. 14 (7). Date of Electronic Publication: 2023 Jul 17.
نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101551097 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4425 (Electronic) Linking ISSN: 20734425 NLM ISO Abbreviation: Genes (Basel) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel : MDPI
مواضيع طبية MeSH: Bipolar Disorder*/genetics , Schizophrenia*/genetics, Humans ; Polymorphism, Single Nucleotide/genetics ; Interleukin-6/genetics ; Genetic Predisposition to Disease ; Depression/genetics ; Cytokines/genetics
مستخلص: Immune gene variants are known to be associated with the risk of psychiatric disorders, their clinical manifestations, and their response to therapy. This narrative review summarizes the current literature over the past decade on the association of polymorphic variants of cytokine genes with risk, severity, and response to treatment for severe mental disorders such as bipolar disorder, depression, and schizophrenia. A search of literature in databases was carried out using keywords related to depressive disorder, bipolar disorder, schizophrenia, inflammation, and cytokines. Gene lists were extracted from publications to identify common genes and pathways for these mental disorders. Associations between polymorphic variants of the IL1B , IL6 , and TNFA genes were the most replicated and relevant in depression. Polymorphic variants of the IL1B , IL6 , IL6R , IL10 , IL17A , and TNFA genes have been associated with schizophrenia. Bipolar disorder has mainly been associated with polymorphic variants of the IL1B gene. Interestingly, the IL6R gene polymorphism (rs2228145) was associated with all three diseases. Some cytokine genes have also been associated with clinical presentation and response to pharmacotherapy. There is also evidence that some specific polymorphic variants may affect the expression of cytokine genes. Thus, the data from this review indicate a link between neuroinflammation and severe mental disorders.
References: Schizophr Res. 2018 Sep;199:292-296. (PMID: 29705005)
Brain Behav Immun. 2018 Mar;69:264-272. (PMID: 29197507)
Front Cell Neurosci. 2020 Aug 27;14:274. (PMID: 33061891)
Sci Rep. 2016 Aug 09;6:31264. (PMID: 27502736)
J Affect Disord. 2019 Feb 15;245:679-685. (PMID: 30447566)
J Affect Disord. 2019 Mar 1;246:42-51. (PMID: 30578945)
Psychoneuroendocrinology. 2013 Sep;38(9):1803-13. (PMID: 23571152)
Brain Behav Immun. 2016 Oct;57:116-124. (PMID: 26971470)
Brain Behav Immun. 2015 Oct;49:206-15. (PMID: 26065825)
Mol Biol Rep. 2013 Oct;40(10):5607-14. (PMID: 24065520)
World J Biol Psychiatry. 2022 Jan;23(1):67-77. (PMID: 33949291)
Front Psychiatry. 2022 Apr 25;13:880568. (PMID: 35546942)
Cell Mol Neurobiol. 2020 Aug;40(6):1049-1056. (PMID: 31912349)
Heliyon. 2019 Jan 07;5(1):e01124. (PMID: 30662970)
Drug Alcohol Depend. 2017 Jul 1;176:71-78. (PMID: 28525828)
Indian J Psychiatry. 2022 Sep-Oct;64(5):484-488. (PMID: 36458089)
Schizophr Res. 2015 Dec;169(1-3):1-9. (PMID: 26481614)
Neuron. 2020 Jul 22;107(2):234-256. (PMID: 32553197)
PLoS Med. 2021 Mar 12;18(3):e1003455. (PMID: 33711016)
Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(3):89-93. (PMID: 29652312)
Pharmacol Biochem Behav. 2020 Sep;196:172981. (PMID: 32621927)
Brain Behav Immun. 2016 Aug;56:96-104. (PMID: 26891860)
Metab Brain Dis. 2016 Feb;31(1):213-24. (PMID: 26481640)
Biomark Med. 2015;9(2):169-80. (PMID: 24524646)
Mol Biol Res Commun. 2016 Mar;5(1):45-48. (PMID: 27844019)
Mol Psychiatry. 2016 Dec;21(12):1696-1709. (PMID: 26903267)
Brain Behav Immun. 2017 Aug;64:367-383. (PMID: 28263786)
Nat Genet. 2018 May;50(5):668-681. (PMID: 29700475)
Psychiatry Res. 2016 Jun 30;240:314-320. (PMID: 27138824)
Schizophr Res. 2018 Dec;202:64-71. (PMID: 30025760)
Arch Immunol Ther Exp (Warsz). 2016 Dec;64(Suppl 1):161-168. (PMID: 28083609)
Physiol Behav. 2014 Apr 22;129:194-8. (PMID: 24576679)
Pharmacogenomics. 2015 Nov;16(17):1919-29. (PMID: 26556688)
Am J Geriatr Psychiatry. 2017 Dec;25(12):1300-1308. (PMID: 28844626)
Front Psychiatry. 2020 Mar 12;11:94. (PMID: 32226396)
Psychol Med. 2021 Apr;51(6):894-901. (PMID: 33843505)
J Neuroinflammation. 2020 Feb 15;17(1):56. (PMID: 32061259)
Eur Psychiatry. 2019 Aug;60:7-13. (PMID: 31100612)
Transl Psychiatry. 2019 Sep 18;9(1):233. (PMID: 31534116)
J Neuroimmunol. 2016 Apr 15;293:123-128. (PMID: 27049572)
Psychiatr Genet. 2021 Apr 1;31(2):72-78. (PMID: 33707400)
Eur J Oncol Nurs. 2013 Jun;17(3):346-53. (PMID: 23187335)
Biomed Rep. 2021 Dec;15(6):105. (PMID: 34760278)
Int J Mol Sci. 2023 Jan 22;24(3):. (PMID: 36768537)
Lancet Psychiatry. 2023 Apr;10(4):260-271. (PMID: 36863384)
Lab Med. 2023 May 2;54(3):250-255. (PMID: 36239635)
Clin Breast Cancer. 2022 Oct;22(7):674-680. (PMID: 35918221)
Brain Behav. 2020 Jun;10(6):e01628. (PMID: 32307924)
Brain Behav Immun. 2021 Oct;97:176-185. (PMID: 34280516)
Neurosci Lett. 2016 May 27;622:107-12. (PMID: 27001087)
Neuropsychopharmacology. 2017 Jan;42(1):81-98. (PMID: 27555379)
Biol Res Nurs. 2015 May;17(3):237-47. (PMID: 25304131)
Support Care Cancer. 2013 Nov;21(11):3117-25. (PMID: 23852407)
Int J Clin Exp Med. 2014 Sep 15;7(9):2851-7. (PMID: 25356148)
Front Psychiatry. 2019 Mar 22;10:151. (PMID: 30967802)
Psychiatry Res. 2020 Nov;293:113421. (PMID: 32920525)
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(3):74-79. (PMID: 28399100)
Neuropsychopharmacology. 2017 Jan;42(2):419-426. (PMID: 27430614)
Psychol Med. 2019 Jul;49(10):1749-1757. (PMID: 30688187)
Front Pharmacol. 2021 Apr 12;12:640032. (PMID: 33995044)
CNS Drugs. 2023 Mar;37(3):243-253. (PMID: 36763263)
J Neural Transm (Vienna). 2016 May;123(5):541-8. (PMID: 26821321)
PeerJ. 2020 Feb 25;8:e8676. (PMID: 32140313)
World J Biol Psychiatry. 2023 Mar;24(3):243-253. (PMID: 35818961)
J Psychiatr Res. 2018 Jul;102:192-200. (PMID: 29684628)
Brain Sci. 2023 May 22;13(5):. (PMID: 37239308)
J Affect Disord. 2013 Sep 5;150(2):668-72. (PMID: 23608119)
Brain Behav Immun. 2015 May;46:104-11. (PMID: 25596176)
CNS Neurol Disord Drug Targets. 2018 Apr 26;17(1):69-74. (PMID: 29424322)
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jan 4;72:55-59. (PMID: 27608541)
Eur J Oncol Nurs. 2014 Aug;18(4):397-404. (PMID: 24726621)
Int J Neuropsychopharmacol. 2023 Mar 22;26(3):189-197. (PMID: 36472886)
Front Neuroendocrinol. 2020 Jan;56:100800. (PMID: 31654681)
Psychiatry Res. 2021 Feb;296:113606. (PMID: 33348197)
Eur J Neurosci. 2021 Jan;53(1):151-171. (PMID: 32150310)
J Psychiatr Res. 2020 Mar;122:33-41. (PMID: 31918351)
J Affect Disord. 2013 May 15;148(1):57-65. (PMID: 23276701)
Prog Neuropsychopharmacol Biol Psychiatry. 2022 Jun 8;116:110534. (PMID: 35150783)
Brain Behav Immun. 2020 Aug;88:547-558. (PMID: 32330592)
N Am J Med Sci. 2014 Nov;6(11):558-65. (PMID: 25535603)
Nat Rev Immunol. 2017 Jan;17(1):49-59. (PMID: 27916979)
Psychoneuroendocrinology. 2016 Jun;68:140-7. (PMID: 26974498)
Brain Behav Immun. 2018 Jul;71:28-36. (PMID: 29730395)
J Neuropsychiatry Clin Neurosci. 2013 Winter;25(1):72-82. (PMID: 23487197)
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 8;105:110136. (PMID: 33045321)
J Affect Disord. 2019 Sep 1;256:578-583. (PMID: 31280083)
Compr Psychiatry. 2020 Feb;97:152159. (PMID: 31931428)
Cytokine. 2018 Nov;111:112-118. (PMID: 30138899)
Acta Psychiatr Scand. 2017 May;135(5):373-387. (PMID: 28122130)
Iran J Allergy Asthma Immunol. 2016 Dec;15(6):466-475. (PMID: 28129679)
Brain Behav Immun. 2021 Oct;97:193-203. (PMID: 34332041)
J Neurol Neurosurg Psychiatry. 2015 Sep;86(9):1002-7. (PMID: 25315113)
J Neuroinflammation. 2016 May 13;13(1):105. (PMID: 27177030)
فهرسة مساهمة: Keywords: SNP; bipolar disorder; cytokines; depressive disorder; genetic association; genetic markers; schizophrenia; single nucleotide polymorphisms
المشرفين على المادة: 0 (Interleukin-6)
0 (Cytokines)
تواريخ الأحداث: Date Created: 20230729 Date Completed: 20230731 Latest Revision: 20230801
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10379485
DOI: 10.3390/genes14071460
PMID: 37510364
قاعدة البيانات: MEDLINE
الوصف
تدمد:2073-4425
DOI:10.3390/genes14071460